- Works count
- 375
- Citation count
- 6,185
- H-index
- 34
- i10-index
- 85
Research interests
Publications
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)00456-1
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
Circulation · 2022 · https://doi.org/10.1161/circulationaha.122.061612
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction
JAMA · 2021 · https://doi.org/10.1001/jama.2021.18463
Effect of Home-Based Telemonitoring Using Mobile Phone Technology on the Outcome of Heart Failure Patients After an Episode of Acute Decompensation: Randomized Controlled Trial
Journal of Medical Internet Research · 2009 · https://doi.org/10.2196/jmir.1252
Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions
European Heart Journal · 2005 · https://doi.org/10.1093/eurheartj/ehi504
Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease
Circulation · 2003 · https://doi.org/10.1161/01.cir.0000105767.94169.e3
Subclinical hyperthyroidism as a risk factor for atrial fibrillation
American Heart Journal · 2001 · https://doi.org/10.1067/mhj.2001.119370
Current projects
No projects listed.